PAIRED EXCHANGE KIDNEY TRANSPLANTATION EXPERIENCE OF TURKEY

Levent Yucetin MD.

Antalya Medicalpark Healthcare Group Transplant Center

Senior Transplant Coordinator

S.Tilif, N.Kececıoglu, O.Yanik, S.Kacar, A.Dınckan, M.Tuncer

Goztepe Medıcalpark Hospital,

Akdeniz University Transplant Center

T Ü R K İ Y E

74 MILLIONS

59 Kidney tx centers 24 Liver tx centers 12 Heart tx centers

2500 Kidney tx per year

3 paired exchange programmes

The number of cadaveric donation rate is 3,2 pmp for 2010 in Turkey.

The number of patients on dialysis 60.000 and kidney transplantation from cadaveric donors 395 and 2107 from living donors in 2010. There is a big gap between the number of ESRD patients and transplantation.

KIDNEY TRANSPLANTATION PER YEAR ACCORDING TO CENTERS

ANTALYA MEDICALPARK 500

GOZTEPE MEDICALPARK 200-250

AKDENIZ UNIVERSITY 200-250

Between 2005 and 2011 , a total of 272 paired exchange live kidney transplantation were

performed at three transplant centers.

Every center has their own paired exchange

waiting list.

Demogrative datas of donors and recipients

DONOR RECIPIENTMALE 101 171FEMALE 171 101MARRIED 99 102SINGLE 17 9AGE 19-77(47,84+11,19) 5-74(42,63+13,40)PREEMTİVE 30HEMODIALYSIS TIME 0-212(37,34+41,91)CAPD TIME 0-120(14,81+27,53)HBS AG (+) 2 6HCV AB (+) 0 9

168 of the donors were spouse and 52 of them were parents.

RELATIONSHIP NUMBER PARENT 52SIBLING 19SPOUSE 168

CHILDREN 2OTHER 31

The donors should be a relatif till 4th degree and documented by goverment.

The marriage should be more than 2 years.

229 of them were conventional and

43 of them were unconventional transplantation.

BLOOD GROUP RECIPIENT DONORA 126 124B 103 101O 43 47

269 were two-relay, 2 three-relay, 1 four-relay.

The HLA missmatch average is 3,37+1,85(0-6).

3 years patient survival 98,7 and greft survival 96,9.

Paired donation may expand the living donor pool and decrease the number of patient on the waiting list.

The advantages of a living donor transplant are well

documented. They include improved long-term graft

survival, a lower rate of delayed graft function, the possibilty

of pre-emtive transplantation and less time spent on dialysis.

It is cost effective according to ABO incompetatible

transplantation.

Thank you for your attention.